Pharmacologic mediators of bronchoconstriction.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D012898:Autacoids / Q000502:physiology*; D001491:Basophils / Q000378:metabolism; D001980:Bronchi; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids; D006967:Hypersensitivity / Q000378:metabolism; D066298:In Vitro Techniques; D007249:Inflammation / Q000378:metabolism; D008407:Mast Cells / Q000378:metabolism; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D051381:Rats; D013189:SRS-A / Q000502:physiology
D001095:Arachidonic Acids; D012898:Autacoids; D006893:Hydroxyeicosatetraenoic Acids; D013189:SRS-A; C022022:5-hydroxy-6,8,11,14-eicosatetraenoic acid